.png)
Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., is a growing international
molecular imaging company focused on delivering innovative, well‐differentiated diagnostic solutions
that inform patient care. Formed in 2014, the Company’s success is driven by its management expertise
and supported by a demonstrated track record of rapid development and commercialization of positron
emission tomography (PET) radiopharmaceuticals. Blue Earth Diagnostics’ expanding oncology portfolio
encompasses a variety of disease states, including prostate cancer and neuro‐oncology. Blue Earth
Diagnostics is committed to the timely development and commercialization of precision
radiopharmaceuticals for potential use in imaging and therapy. For more information, please visit:
www.blueearthdiagnostics.com.